Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-DOPA-PET for Glioma Surgical Planning
NCT02020720Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2014
- Primary completion
- Oct 2019
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Mayo Clinic. Primary endpoint: Ratios of maximum tumor standardized uptake value (SUVmax) normalized to mean SUV (SUVmean) of T/N up to 1 year. Started Jan 2014; status: completed.
Beyond the preview
Go deeper on NCT02020720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02020720.